10x Genomics, Inc. TXG recently announced a multi-project research collaboration with Fred Hutchinson Cancer Center to ...

The initiative represents the first time 10x Genomics widened its scope past solid tumours to include haematologic ...

Multi-project collaboration with Fred Hutch Cancer Center spans biomarker discovery in bladder cancer and a single cell ...

Learn more 10x Genomics (TXG) said Wednesday it entered into a multi-project research collaboration with Fred Hutchinson Cancer Center to advance single-cell and spatial technologies across solid ...

A cross-sectional study evaluated oncology nurses' readiness, knowledge, and confidence in incorporating genomics into practice to identify educational needs for cancer care.

Veracyte has acquired Convergent Genomics in a transaction valued at up to $180 million, adding the UroAmp urinary tumor DNA platform to its cancer diagnostics portfolio and expanding its ability to ...

PRNewswire/ -- (Nasdaq: TXG), the life science technology leader focused on accelerating science and advancing human health, ...

The era of predictive genomics is rapidly reshaping how we think about disease, risk and lifelong health. Recent advances in whole-genome sequencing have equipped clinicians with insights into our ...

WhiteLab Genomics has raised $26 million in Series B financing to expand its artificial intelligence platform for designing ...

Cancer genomics is the study of the totality of DNA sequence and gene expression differences between tumour cells and normal host cells. It aims to understand the genetic basis of tumour cell ...

Discover how India is embracing genomics in healthcare with insights from the India Precision Health & Genomics Leadership ...

It started with idea to help beleaguered fishermen. Now marine science lab promotes healthy fisheries, trains local workforce ...